The Committee is grateful to the Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare (MOHW), and Ministry of Agriculture (MOA) for their recognition of and support for our previous suggestions. To effectively address climate change and maintain food security, we urge the authorities to consider our latest suggestions and continue to improve relevant management policies in accelerating the introduction of new pesticide products that are highly safe, efficient, and low-intensity, as well as new technologies for promoting breeding innovation. Doing so will help reduce environmental harm and enable agricultural sustainability. Further, we urge the MOA to accelerate the revision schedule for the Agro-pesticides Management Act.
Suggestion 1: Accelerate revision of Article 14 of the Agro-pesticides Management Act and related labeling regulations.
This suggestion has been brought up in every White Paper since 2019, but no progress has occurred. Article 14 of the Act provides that following the MOEA’s approval of changes in a pesticide label, all relevant products must be relabeled within six months. Such a requirement is reasonable for changes potentially affecting the safety of a product. However, if the change has no impact on farmers’ safe use of pesticides, there is no need for a product already on the market to be withdrawn for relabeling.
Following the approval of new labeling, the procedures for either recalling products from the market or replacing labels have become overly complicated and burdensome, leading to significant costs. Moreover, the requirement that labels cannot be updated by merely marking the change, modifying the adhesive label, or affixing a new adhesive label over the old one necessitates that products (such as those in aluminum sacks) be unpacked and then repacked, which in turn raises occupational safety concerns about the repeated exposure of workers to these products during the process.
Further complicating matters are sporadic announcements from the government regarding changes in the use pattern or cautionary notes about individual products, as these necessitate re-approval of the label if any license has been submitted for renewal or amendment. This requirement wastes resources and results in additional costs, including the destruction of existing inventory labels and the labor-intensive process of unpacking and repacking recalled products.
Recommendations:
- Fast-track revisions to Article 14 of the Agro-pesticides Management Act. Since 2019, the Committee has been calling for amendments, such as removal of the mandate to recall products within six months due to minor label amendments that do not affect safety or manufacturing, but has yet to see any substantial action or even receive a formal reply. We urge the Animal and Plant Health Inspection Agency (APHIA) to confirm that our proposed amendment to Article 14 is among the prospective revisions. Furthermore, we urge APHIA to accelerate the drafting process, enabling a bill to be submitted for legislative approval without further delay.
- Add a positive list in the Enforcement Rules of the Agro-pesticides Management Act specifying the types of changes that do not require relabeling. Changes such as the name of the manufacturer, extension of product shelf life, and modifications to packaging, labeling design, and barcodes have no impact on product safety. The practice of allowing such modifications without relabeling is already common in other industries. To avoid unnecessary costs and waste, and in consideration of industry practice, the sale of products should be allowed to continue until their expiry dates.
Suggestion 2: Expedite the review process for new active ingredients and products with new content or new formulations.
Under APHIA’s 10-year plan to reduce the volume of chemical pesticide usage by half, companies are encouraged to register pesticides with high safety, low dosage, and specificity to reduce the risks of pesticide exposure to farmers, as well as to mitigate negative environmental impact. Achieving that goal will require the approval of products with new active ingredients and new formulations.
Whether for pesticide registration, renewal, or re-registration, however, the proportion of application approvals for new active ingredients and new formulation products has been minimal. Statistics compiled by APHIA’s Agricultural Information Network show that of the 229 certificates issued in 2023, only 3 were for new active ingredients. In 2022, 296 certificates were issued, with a mere 9 dedicated to new active ingredients. Additionally, on the list of active ingredients that have passed the 15-year pesticide re-registration, 20 active ingredients were approved in 2023, much fewer than the 34 approved in 2022.
We urge APHIA to prioritize the allocation of its review and administrative capacities toward innovative products, such as those with new active ingredients and new formulations. This prioritization would spur the launch of innovative products and aid the elimination of high-hazard or high-risk formulation products.
Suggestion 3: Accelerate the administrative process for determining the maximum residue limits for pesticides.
We are grateful to the TFDA and the MOHW for their commendable efforts in increasing the frequency of announcements regarding the maximum residue limits (MRLs) of pesticides. The TFDA has consistently issued official announcements on MRLs at least three times annually, a practice that greatly benefits stakeholders by providing clearer regulatory guidance.
Despite these improvements, several aspects of the administrative procedures for pesticide registration remain unclear. These ambiguities have caused delays in the registration process, significantly impacting applicants who have made substantial investments in Taiwan. Uncertainty regarding the following points has made it challenging for applicants to predict the approval timeline for their applications:
- The timeline for sending cases to APHIA to schedule review by the Pesticide Advisory Committee under the MOA after the cases have passed review by the Agricultural Chemicals Research Institute.
- The timeline for sending cases to the TFDA after they have passed the Pesticide Advisory Committee’s review.
- The timeline for arranging document reviews by experts and comprehensive review by the Food Sanitation, Safety and Nutrition Advisory Committee after the TFDA has received a case.
- Following case reviews, the various required administrative procedures and joint actions involving some 20 functional offices or units. These procedures may take more than one month, not including the time required for subsequent pre-notification and official announcement of related regulations, which may take at least another four months.
- APHIA’s informal pre-notification procedure that, although officially optional, is being enforced as if mandatory. Completing this process can take up to two months. APHIA has advised the Committee that applicants are expected to initiate direct communication with the TFDA, requesting that it notify APHIA about the contents of any forthcoming announcement prior to its public disclosure. In practice, this procedure significantly delays APHIA’s ability to announce the approved use pattern of registration after the TFDA discloses the finalized MRLs. This extended timeline for procedural compliance not only complicates the registration process but also affects the timely introduction and use of registered products, hindering the efficient management and implementation of agricultural practices.
- The requirement that companies await an official announcement from APHIA before proceeding with applications for permits or changes in labeling. This administrative procedure alone can take at least one month.
We urge departments within the MOA and the MOHW to establish and clearly define the procedures and precise timings of administrative processes at both the ministerial and departmental levels. Clarifying these procedures would help streamline the administrative process to the benefit of all stakeholders.
Additionally, we ask that these procedural details be made available to the public. Such transparency could significantly enhance horizontal communication across different ministries and departments, leading to a more coordinated and efficient administrative process.
Suggestion 4: Reassess the reasonableness of data requirements for registering generic pesticides to ensure safe and effective use by farmers.
The Committee has raised this issue in the past four White Paper issues, but no progress has been made. Compared to the regulatory frameworks in other countries for registering generic agricultural products, the procedure in Taiwan stands out for its conciseness, requiring only the submission of physical and chemical data. This approach focuses on ensuring that the active ingredients and formulation type of the generic product match those of the originally registered product.
However, other ingredients in the product may differ from what was covered in the original comprehensively evaluated registration. This discrepancy in composition raises concerns about the efficacy of the generic products, as it cannot be guaranteed to fully match that of the original products. As a result, farmers may inadvertently overuse these products or use them in ways that deviate from the government’s pesticide reduction policy.
Recommendations:
- Revise current legislation to mandate at least one field test assessing the efficacy of generic pesticides on the crops for which registration is sought.
- Require the submission of comprehensive toxicological data for the registration of generic products. Data should include reports on oral-, dermal-, and inhalation-acute toxicity, as well as eye irritation tests, to unequivocally demonstrate the safety of the generic products for users.
- Formalize the registration process for generic pesticides. This process should include evaluation by the MOA’s Pesticide Advisory Committee for the generic product’s necessity, efficacy, and safety before approval is granted. Such measures will ensure that generic pesticides introduced into the market meet the expected high standards of performance and safety, thereby protecting users and supporting the goals of pesticide reduction and sustainable agriculture practices.
Suggestion 5: Set up a transparent regulatory frame-work with a predictable timeline and adopt a product-based regulatory approach harmonized with Taiwan’s major trading partners for genome-edited products.
Agricultural innovation has played an essential role in increasing yields and productivity in support of growing, prosperous civilizations. Moreover, considering the rapidly growing world population, climate change, and increasing scarcity of natural resources such as arable land and water, progress in plant propagation has gained unprecedented importance.
High-yielding crops of superior nutritional value that can be grown more resource-efficiently are increasingly becoming the cornerstone of sustainable yet highly productive agriculture. In addition, there is a need to make crops more pest- and disease-resistant as well as more tolerant to adverse conditions such as drought, heat, submergence, and salinity. Innovations in precision biotechnology, such as gene editing, are therefore required to enhance the speed, predictability, precision, and success rate of plant breeding.
As highlighted in the 2023 White Paper, the World Trade Organization released the joint International Statement on Agricultural Applications of Precision Biotechnology, supported by 10 members, urging governments to implement science-based and globally harmonized policies for precision biotechnology. To support agricultural innovation, many of Taiwan’s key trading partners – including Argentina, Australia, Brazil, India, Japan, the Philippines, and the United States – have since implemented well-functioning and proportionate regulatory systems. These markets have exemptions granted certain types of gene-edited crops from their GMO regulations. Furthermore, the exemption by some government agencies can be evaluated and confirmed through a pre-consultation mechanism.
Over the past 12 months, some countries and regions have made further noteworthy progress in developing policies for the management of genome-edited products. For example, the European Commission released its New Genomic Techniques (NGT) proposal for new regulation on plants produced by certain new genomic techniques (for example, gene-editing technology) on July 5, 2023. The Commission also proposed that Category 1 NGT plants should be exempted from the requirements of GMO legislation, affirming the Commission’s position that plants derived from these technologies have safety profiles comparable to conventional counterparts and may contribute to sustainable agriculture and the European Union’s Farm to Fork Strategy, as concluded in the NGT study published on April 29, 2021.
On December 20, 2023, the Singapore Food Agency released a policy document for public consultation on the regulatory framework for genome-edited crops for food and feed. This document proposed that plants that do not contain foreign DNA should be exempted from pre-market safety assessment. On January 18, 2024, Thailand’s Technical Biosafety Committee approved the Guidelines for Consideration of Genome Editing, stipulating that products lacking novel genetic combinations or foreign genetic sequences should be exempt from GMO regulation.
These recent policy developments have demonstrated the importance of precision biotechnology such as gene editing to address challenges in agricultural production as well as to support food sufficiency and achieve sustainability goals.
Taiwan is a key global trading partner for agricultural products, including seed and plant products. To help Taiwan maintain a competitive and secure food and feed supply, we urge the government to establish a transparent regulatory framework with predictable timelines and adopt a product-based regulatory approach for gene-edited products to ensure harmonization with Taiwan’s major trading partners.
委員會感謝政府持續地努力,促進與產業利害關係人之間的雙向溝通。我們鼓勵相關部會持續秉持開放合作的承諾,確保化學品管理的持續精進。
今年,委員會籲請環境部制定兼顧風險管理與產業發展的全氟和多氟烷基物質(PFAS)管理政策,改進新化學物質登錄制度,並完善下游使用效率和暴露資訊蒐集制度。此外,我們亦呼籲中央政府加強對台灣化學品管理策略之溝通,並深化與產業界之合作。重點應放在統整跨部會化學品通報規範,以及有效運用危害與暴露評估資訊。
議題一:依據科學證據、國際準則與社會經濟考量,制定兼顧平衡的PFAS管理政策
- 建立以科學證據為基礎的PFAS法規管理架構
全氟和多氟烷基物質(PFAS)具高度穩定性,對酸、鹼和溶劑具有強大的耐受性,使其在再生能源、汽車、醫療和科技等關鍵產業中扮演至關重要的角色。然而,因其具環境具持久性,以及潛在的健康風險,已逐漸引起國際關注,並促使各國加強相關立法與監管。
委員會敦促環境部化學物質管理署於建立台灣PFAS管理架構時,應以科學證據為依據,確保法規之制定嚴謹且透明性,並應訂定清晰明確的監管目標,包括風險降低策略與合理的合規期程,以提供企業明確的指引。此外,亦應賦予企業充分時間進行評估作業,並廣納產業界之意見與建議。在監管層面,委員會進一步建議化學物質管理署依循科學原則規劃PFAS管理策略,以確保業者得以清楚、一致且可行地遵循要求。
化學文摘社(CAS)登記號碼系統於美國被廣泛應用,提供一套精確且國際普遍認可的化學分類架構。CAS 編號系統可消弭化學命名上的模糊性,並整合現有資料與研究成果,有助於法規判斷與合規作業之推動。台灣現行之既有化學物質清冊(TCSI)已部分採納 CAS 編號系統,為提升監管之透明度和效率,我們建議進一步強化TCSI與CAS系統之整合,使化學管理建立於一致性的基礎上,以降低誤判風險,並簡化在國內外業者外之合規流程。 - 接軌國際PFAS管理方針
為保護人類健康和環境,《斯德哥爾摩公約》已將部分PFAS(如全氟辛酸、全氟辛烷磺酸和全氟己烷磺酸)列為危害物質,該公約迄今已有180多餘國簽署。為回應此公約,數個先進經濟體已啟動監管調查,並依據國際承諾或國內政策,制定相關法規以限制特定PFAS的使用,同時鼓勵業界開發更安全的替代品。
委員會建議參採歐盟或加拿大的作法,根據特定產業的價值鏈進行系統性評估,據以合理且有根據之監管決策。此一方法有助於在限制及逐步淘汰特定物質、尋求可行替代方案之際,兼顧對環境與健康的保護,以及產業合規之經濟可行性。
為進一步使台灣的PFAS監管架構與國際接軌,我們鼓勵化學物質管理署參考美國國家環境保護局的PFAS管理行動計畫。該計畫提供一套具架構的管理依據,以降低風險、協助企業順應立法過渡並維護環境安全。 - 支持產業切實順應立法過渡與合規策略
根據半導體行業協會(SIA)之調查,替代應用於半導體製程的PFAS至少需時15年。過於激進的立法可能使台灣企業面臨重大合規挑戰,進而衝擊無法以其他物質替代PFAS之產業,並可能損害台灣在先進技術領域的領導地位。
氟聚合物是PFAS中一個獨特的子類別,具有與其他PFAS化合物明顯不同的化學特性。這些大型且穩定的分子不溶於水,亦不具生物可利用性與生物蓄積性,亦非屬於化學品全球調和制度(GHS)之定義之危害物質。氟聚合物於半導體基礎設施、設備及耗材中具關鍵功能,為台灣的高科技產業不可或缺之一環。基於其獨特性,監管架構應區別氟聚合物與其他PFAS化合物,以避免產業受到不必要之干擾。
目前並無可取代氟聚合物之物質能達到台灣先進產業所需之高性能標準。鑒於氟聚合物其在半導體製程、可再生能源及其他高科技產業部門中所扮演之關鍵角色,任何法規之訂定皆應審慎考慮替代品之可得性,以避免產業遭受意料之外之衝擊。
為追求永續發展目標與維持產業競爭力,委員會建議依物質特性採差異化管理PFAS。舉例而言:得依據物質風險與性質區分管理氟聚合物,將氟聚合物、氫氟烯烴等無 GHS 危害分類之 PFAS ,與具 GHS 危害分類之物質加以區別。此舉利於產業分階段調整製程,同時符合監管要求。透過優先發展研發、強化產業合作機制及採行漸進式立法,將有助於法規監管兼顧環境永續與高科技產業之持續發展。 - 強化產官交流以促進有效的法規制定
委員會呼籲化學物質管理署應與經濟部和衛生福利部等相關部門密切合作,全面評估PFAS的安全性及其對環境和經濟之影響為促進持續對話,委員會建議依循 2023 年國家化學物質管理委員會所制定的「全氟及多氟烷基物質 (PFAS) 管理行動計畫」,擴大舉辦產官交流會議。該計畫亦成功強化各部會間在危害性化學品管理上的協調機制。依據行動方案規劃,利害關係人會議應至少每年召開一次,並得視實際需要機動召集,以作為協調與指導本倡議中PFAS管理推動策略之平台。透過定期召開利害關係人諮詢會議,將有助於提升決策過程之透明度,並確保資訊的完整性與可近性,進而確保相關法規兼顧科學實證與產業實務之實際需求。 - 增強公共衛生保護,並避免對產業造成干擾
- 針對公共衛生疑慮,特別是關於食品安全和消費性產品,應從源頭控管及後市場稽查兩方面著手。委員會呼籲衛生福利部加強對食品包裝和化妝品中PFAS的監管措施,以降低潛在的健康風險。
- 委員會呼籲與經濟部攜手合作,以強化研發量能,確保產業獲得必要的支持,發展具可行性之PFAS替代品。委員會鼓勵化學署能廣納學界與業界的經驗與建議,導入適切之管理策略,以在保護台灣環境和公共健康的同時,維持經濟之穩定成長。
議題二:改進新化學物質登錄制度及其配套機制與措施,以促進產業研發創新並接軌國際實務
台灣在全球半導體及電子產業中扮演著關鍵角色,化學品的研發創新更因而亦顯重要。隨著主管機關在實現永續目標的過程中,日益強化法規管制並積極推動綠色化學,業界正積極尋找可行且安全的替代物質,而這些新研發及製造的化學品多屬於新化學物質。
自民國103年施行《新化學物質及既有化學物質資料登錄辦法》以來,儘管該辦法已多次修正並發布指引,但監管要求與業界實際面臨之挑戰仍存在落差。現行的新化學物質登錄制度大幅增加企業的行政負擔,不僅阻礙創新,亦延宕自研究開發至生產的時程。例如:針對每年100公斤以下的新化學物質,其登錄期程通常約一個月方能完成,考量產業每日樣品流通量甚鉅,對於僅數公斤之小量新物質而言,所需時間與行政作業已對台灣的創新構成重大阻礙。
相較之下,主要產業競爭對手韓國於今年1月修法,簡化新化學物質的登錄流程,將申報門檻由0.1公噸/年提升至1公噸/年,並以申報代替登錄,企業在提出申請後七日內便可獲得核准。
為在可控風險的前提下提升監管效率,委員會建議化學署適時檢討並滾動修正新化學物質登錄門檻,對於輸入或製造量低於 1 公噸/年之新化學物質,建議由登錄制度調整為備查方式,簡化應提交之資料及相關行政流程,以完整性確認取代實質審查。此舉將能降低業者的合規負擔、支持化學產業創新研發,並使台灣的監管架構更加與國際最佳實踐接軌。
此外,雖然現行法規已設有新化學物質「共同登錄」之規定,但多年來卻缺乏具體配套機制。化學品供應鏈需具備彈性,原登錄人已完成該物質之登錄,當國外製造商及其國內進口商之客戶欲自行進口物質或含有該物質之配方產品時,在不超過原登錄噸位之條件下,應允許其與原登錄人進行共同登錄。
共同登錄可避免重複審查相同卷宗,減少主管機關的行政負擔,並顯著降低化學產業的合規壓力。建立新化學物質共同登錄之配套機制,將有助於提升監管效率,同時確保持續且有效的管理。
議題三:完善登錄案件下游使用與暴露資訊蒐集流程,提高業者合規效率
近兩年來,越來越多業者反映接獲主管機關要求其提供更下游客戶運作資訊。此類要求不僅出現在既有及新化學物質之標準登錄案件中,亦包括須附以附款之案件。
委員會理解化學署需掌握物質在國內運作情形與流向,然而,作為登錄人,業者實難強制下游客戶,或要求價值鏈中更下游參與者(如經銷商的客戶),提供詳實的使用及暴露資訊,亦難以驗證該等資訊之準確性。
因此,委員會建議化學署能在法規層面,完善登錄案件中下游使用及暴露之資訊蒐集流程,明定登錄人僅須揭露下一層客戶資訊及產品名稱,以利主管機關可逕行向下游業者取得所需資料,同時兼顧商業機密之保護並減輕產業的行政負擔。
雖目前須附以附款的案件在國內仍屬少數,然委員會注意到,近年來附以附款對業者營運所造成之負擔有日漸增加之趨勢。現行實務上,業者多於登錄流程末期方獲知申請物質具有疑似毒性化學物質的特性,並接獲化學署通知,研商就附以附款及可能的限制進行研商。此類後期通知限制企業預先規劃之彈性,亦增加行政成本和監管的不確定性。
因此,委員會建議化學署就具有附以附款可能性之物質特性,建立更公開、透明且明確之指引,使業者能於早期即評估整體的行政與合規成本,俾利企業於新產品引進初期做出審慎決策。
議題四:透過改善溝通、促進業界參與和協調監管,建構國家化學品管理政策之長遠願景
在後「國際化學品管理策略方針」(UN Strategic Approach to International Chemical Management, SAICM) 時期,因應全球化學品消費與生產型態日益複雜,委員會呼籲主管機關於國家化學品管理政策制定上,應參酌國際經驗及產業實務,建立與業界之溝通機制,協調整合跨部會間之化學品管理方針。
儘管政府已規劃建構涵蓋政府機關、產業界、學術界及公眾之化學物質管理政策徵詢機制,惟產業界實質參與之機會仍顯不足。對於制定兼顧環境保護與經濟永續發展之有效法規而言,確保產業利害關係人之參與尤為關鍵。同時,考量各國化學品管理架構之差異,主管機關應主動蒐集國際最佳實務。借重跨國企業對全球法規趨勢與合規策略之觀察與經驗,以強化本土化學品管理體系之前瞻性。
近年來,行政機關為統整各部會化學品政策與資訊,已設立跨部會平台,並彙集各類化學物質與化學品的申報資料。然在政策傳達與執行層面,仍存在資訊不一致的情形;以硫酸與甲苯為例,兩者早在2019年即被化學署列入「應完成既有化學物質標準登錄」之名單,並要求業者提交本土危害及暴露評估報告;然於2024年下半年,勞動部職業安全衛生署根據勞動及職業安全衛生研究所之研究成果《甲類危險性工作場所危害物種類及數量之妥適性研究》,提案將該兩物質列為甲類工作場所建議新增管理之前十項物質。
此案例凸顯政策溝通與整合機制仍存斷裂,導致訊息分散、缺乏協調。儘管各主管機關均依職掌針對危害性化學品進行管理,然欠缺一致性與即時共享機制,導致產業界面臨高度的不確定性。唯有建構跨部會間資訊共享與協調機制,始能有效降低企業合規挑戰,提升整體法規之透明度與預測性。
委員會認為,針對既有化學物質標準登錄所產出的危害與暴露評估報告,應作為反映國內現況的主要依據,並建議主管機關以此為基礎進行情境評估,而非單純倚賴委外機構的研究成果。該登錄制度已執行多年,惟各部會在化學品管理上的政策各自為政,協調機制仍待強化。針對以委外研究提出之新增列管物質建議,更顯建立部會間協作機制之急迫性。
委員會成員亦觀察到,近兩年數起重大工廠火災事件,部分原因係工廠未如實申報或更新其化學品使用與儲存資料,事故應變風險評估出現誤判,進而加劇災損。
為降低災害風險,各主管機關逐步強化申報需求要求,除定期申報外,並增設動態申報制度。例如,依照《工廠危險物品申報辦法》,需於每年一月與七月進行定期申報,除定期申報外,並增設動態申報則應於事實發生次日起十日內完成;根據《優先管理化學品之指定及運作管理辦法》,依照不同類別與屬性,分別於每年四月至九月或每年一月及七月進行定期申報,動態申報,當有變更情形時,僅於超過備查門檻數量時適用,並於事實發生之日起三十日內完成。委員會肯定各部會在化學品製造、進口、處置與使用等各層面管理上的努力;然而,申報時程不一,造成業者第一線執行人員不必要的負擔。委員會建議主管機關建立一致性的國家化學品管理申報制度,允許企業透過單一平台並依統一時程完成所有必要申報,取代現行跨平台、多時間節點的申報模式。
因此,委員會建請政府強化部會間協作,建立更有效的跨部會調和機制,以確保業者在面對不同主管機關時,皆能獲得適切且一致的指引,並且增加業界參與討論,建立更開放的溝通管道,促使化學品業者分享國際間的運作經驗,進而促進國際交流機會並與全球管理趨勢接軌。委員會亦呼籲政府積極與產業界合作,共同強化台灣化學品管理策略,為環境與民眾健康提供更堅實的保障。

